Endurance Wealth Management, Inc. Astrazeneca PLC Transaction History
Endurance Wealth Management, Inc.
- $731 Million
- Q2 2023
A detailed history of Endurance Wealth Management, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Endurance Wealth Management, Inc. holds 618 shares of AZN stock, worth $44,137. This represents 0.01% of its overall portfolio holdings.
Number of Shares
618
Previous 618
-0.0%
Holding current value
$44,137
Previous $43,000
2.33%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding AZN
# of Institutions
1,345Shares Held
492MCall Options Held
4.99MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$4.64 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.04 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$2.9 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.62 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.26 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $221B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...